Gut bacteria are to blame for the failure of immune checkpoint therapy for ovarian cancer, new research reveals.

She has a background in neuroscience ... team collaborate with other scientists to investigate the processes and factors that contribute to ovarian cancer metastasis in the hope that their research ...

University of Virginia Cancer Center researchers have explained the failure of immune checkpoint therapy for ovarian cancer by discovering how gut bacteria interfere with the treatment.

Traditionally, chemotherapy was given after surgery (primary cytoreductive surgery (PCRS) and adjuvant chemotherapy). However, chemotherapy can be used before surgery (neoadjuvant chemotherapy (NACT) ...

Background: Variable rates of HER2 protein ... HER2-positive (fluorescence in situ hybridization [FISH] positive) ovarian cancer progressing under taxane/carboplatin chemotherapy or in early ...